Apeloa Pharmaceutical Co., Ltd (SHE: 000739), a pharmaceutical company based in China, has entered into a partnership with Biocre Tech, a specialist in protein and peptide research headquartered in Shenzhen. The collaboration aims to leverage the expertise of both companies, although financial details of the agreement were not disclosed.
This strategic alliance brings together Apeloa’s pharmaceutical development capabilities with Biocre Tech’s prowess in protein and peptide research, signaling a mutual commitment to advancing pharmaceutical innovation within China.- Flcube.com
